Press Release News By Category » biotech (1244)
Article Listing [ Page 2 of 125 ]

Recombinetics Expands Senior Management Team with Industry Veterans in Agriculture and Biomedicine

Gene-editing leader adds top talent to commercialize rapid growth business lines


Erin Keaney, at Novartis, to present at Drug Design & Medicinal Chemistry
Erin Keaney, Global Discovery Chemistry at Novartis Institutes for BioMedical Research, will give a presentation at 11th Drug Design & Medicinal Chemistry.


Richard Buller, VP at Pfizer, to Give a Keynote at GTCbio’s Biomarker Summit Europe 2016
Richard E. Buller, VP at Pfizer, will give a keynote presentation at GTCbio’s Biomarker Summit Europe 2016.


Dr. Stephen Chang to present at CNS Diseases World Summit 2016
Dr. Stephen Chang, Vice President of R&D at NYSCF will give a presentation at GTCbio’s CNS Diseases World Summit 2016


Active Pharmaceutical Ingredient Market to Witness Growth at Impressive 6.3% CAGR till 2023

Market Research Hub has added a new report titled “Active Pharmaceutical Ingredient Market: Global Industry Analysis, Trends and Forecast 2015 - 2023”


Nortis to Present and Exhibit at the Organ-on-a-Chip World Congress, July 7th - 8th 2016

Nortis, Inc. has been chosen to present at the Select Biosciences 2nd Annual Organ-on-a-Chip World Congress and 3D-Culture conference July 7-8, 2016 in Boston


ProCE & Society for Infectious Disease Pharmacists (SIDP) announce educational partnership: SIDPEC™
New pharmacy/medical education media partnership on infectious disease


JDP Therapeutics Secures $17 Million in Series A Financing

JDP Therapeutics, a late stage specialty pharmaceutical company, announced it secured up to $17 million Series A equity financing led by China based CoSci Med.


Byogy Renewables Appoints Martin Ferguson As Australia Chairman To Support Biofuel Commercialization
Former Australian Energy Minister Supports The Byogy “Alcohol To Jet” Biofuel Platform


Diana Colleluori at Bluebird Bio to present at GTCbio’s Cell & Gene Therapy Conference
Diana Colleluori at Bluebird Bio will discuss, “Quality Control Considerations for Commercialization of Autologous Cell Products” at 3rd Cell & Gene Therapy


Just wanted to thank you guys for publishing my press release this morning, this one release landed under all of my key words. A steady flow of traffic has poured through all day, not to mention the release looks great.
* Results may vary
Our partnership with PR Newswire offers Premium SEO Functionality + Extensive Newswire Distribution.
Professionally Written SEO Press Releases
Professionally written press releases designed for search engines and media.